Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2016, Article ID 2820432, 7 pages
http://dx.doi.org/10.1155/2016/2820432
Research Article

Impact of Lifestyle Intervention on HDL-Induced eNOS Activation and Cholesterol Efflux Capacity in Obese Adolescent

1University of Leipzig, Heart Center Leipzig, Leipzig, Germany
2Antwerp University Hospital, Laboratory of Cellular and Molecular Cardiology, Edegem, Belgium
3Antwerp University Hospital, Department of Pediatrics, Edegem, Belgium
4Cardiovascular Diseases, Department of Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium
5Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Germany
6Zeepreventorium, De Haan, Belgium

Received 7 July 2016; Revised 6 October 2016; Accepted 20 October 2016

Academic Editor: Felix Tanner

Copyright © 2016 Jenny Wesnigk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. De Onis, M. Blössner, and E. Borghi, “Global prevalence and trends of overweight and obesity among preschool children,” American Journal of Clinical Nutrition, vol. 92, no. 5, pp. 1257–1264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. B. Hubert, M. Feinleib, P. M. McNamara, and W. P. Castelli, “Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study,” Circulation, vol. 67, no. 5, pp. 968–977, 1983. View at Publisher · View at Google Scholar · View at Scopus
  3. J. L. Baker, L. W. Olsen, and T. I. A. Sørensen, “Childhood body-mass index and the risk of coronary heart disease in adulthood,” The New England Journal of Medicine, vol. 357, no. 23, pp. 2329–2337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Franks, R. L. Hanson, W. C. Knowler, M. L. Sievers, P. H. Bennett, and H. C. Looker, “Childhood obesity, other cardiovascular risk factors, and premature death,” The New England Journal of Medicine, vol. 362, no. 6, pp. 485–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. Peña, E. Wiltshire, K. MacKenzie et al., “Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4467–4471, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Karpoff, A. Vinet, I. Schuster et al., “Abnormal vascular reactivity at rest and exercise in obese boys,” European Journal of Clinical Investigation, vol. 39, no. 2, pp. 94–102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. U. Förstermann and W. C. Sessa, “Nitric oxide synthases: regulation and function,” European Heart Journal, vol. 33, no. 7, pp. 829–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Gordon, W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber, “High density lipoprotein as a protective factor against coronary heart disease. The Framingham study,” The American Journal of Medicine, vol. 62, no. 5, pp. 707–714, 1977. View at Publisher · View at Google Scholar · View at Scopus
  9. G. G. Schwartz, A. G. Olsson, M. Abt et al., “Effects of dalcetrapib in patients with a recent acute coronary syndrome,” The New England Journal of Medicine, vol. 367, no. 22, pp. 2089–2099, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Dodani, D. G. Grice, and S. Joshi, “Is HDL function as important as HDL quantity in the coronary artery disease risk assessment?” Journal of Clinical Lipidology, vol. 3, no. 2, pp. 70–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. J. Barter, S. Nicholls, K.-A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman, “Antiinflammatory properties of HDL,” Circulation Research, vol. 95, no. 8, pp. 764–772, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Adams, C. Besler, T. Fischer et al., “Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties,” Circulation Research, vol. 113, no. 12, pp. 1345–1355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Besler, K. Heinrich, L. Rohrer et al., “Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease,” The Journal of Clinical Investigation, vol. 121, no. 7, pp. 2693–2708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-R. Nofer, M. Van der Giet, M. Tölle et al., “HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3,” The Journal of Clinical Investigation, vol. 113, no. 4, pp. 569–581, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. A. Sorrentino, C. Besler, L. Rohrer et al., “Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy,” Circulation, vol. 121, no. 1, pp. 110–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Matsuo, A. Oberbach, H. Till et al., “Impaired HDL function in obese adolescents: impact of lifestyle intervention and bariatric surgery,” Obesity, vol. 21, no. 12, pp. E687–E695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Bruyndonckx, V. Y. Hoymans, A. De Guchtenaere et al., “Diet, exercise, and endothelial function in obese adolescents,” Pediatrics, vol. 135, no. 3, pp. e653–e661, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. I. K. Lesná, P. Suchánek, J. Kovář, and R. Poledne, “Life style change and reverse cholesterol transport in obese women,” Physiological Research, vol. 58, no. 1, pp. S33–S38, 2009. View at Google Scholar · View at Scopus
  19. R. J. Havel, H. A. Eder, and J. H. Bragdon, “The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum,” The Journal of Clinical Investigation, vol. 34, no. 9, pp. 1345–1353, 1955. View at Publisher · View at Google Scholar · View at Scopus
  20. A. V. Khera, M. Cuchel, M. de la Llera-Moya et al., “Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis,” The New England Journal of Medicine, vol. 364, no. 2, pp. 127–135, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. I. S. Yuhanna, Y. Zhu, B. E. Cox et al., “High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase,” Nature Medicine, vol. 7, no. 7, pp. 853–857, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. X.-A. Li, W. B. Titlow, B. A. Jackson et al., “High density lipoprotein binding to scavenger receptor, class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner,” Journal of Biological Chemistry, vol. 277, no. 13, pp. 11058–11063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. B. O. Aicher, E. K. Haser, L. A. Freeman et al., “Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function,” Obesity, vol. 20, no. 10, pp. 2057–2062, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Teupe, S. Richter, B. Fisslthaler et al., “Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity,” Circulation, vol. 105, no. 9, pp. 1104–1109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Rader, E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat, “The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis,” Journal of Lipid Research, vol. 50, pp. S189–S194, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Rohatgi, A. Khera, J. D. Berry et al., “HDL cholesterol efflux capacity and incident cardiovascular events,” The New England Journal of Medicine, vol. 371, no. 25, pp. 2383–2393, 2014. View at Publisher · View at Google Scholar · View at Scopus